- Home
- ATXG vs MBRX Comparison
ATXG vs MBRX Comparison
Compare ATXG & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- MBRX
- Stock Information
- Founded
- ATXG 2014
- MBRX 2015
- Country
- ATXG China
- MBRX United States
- Employees
- ATXG N/A
- MBRX N/A
- Industry
- ATXG Professional Services
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ATXG Consumer Discretionary
- MBRX Health Care
- Exchange
- ATXG Nasdaq
- MBRX Nasdaq
- Market Cap
- ATXG 3.8M
- MBRX 11.3M
- IPO Year
- ATXG N/A
- MBRX 2016
- Fundamental
- Price
- ATXG $0.75
- MBRX $1.01
- Analyst Decision
- ATXG
- MBRX Strong Buy
- Analyst Count
- ATXG 0
- MBRX 2
- Target Price
- ATXG N/A
- MBRX $6.00
- AVG Volume (30 Days)
- ATXG 18.5K
- MBRX 273.3K
- Earning Date
- ATXG 02-14-2025
- MBRX 05-13-2025
- Dividend Yield
- ATXG N/A
- MBRX N/A
- EPS Growth
- ATXG N/A
- MBRX N/A
- EPS
- ATXG N/A
- MBRX N/A
- Revenue
- ATXG $4,549,310.00
- MBRX N/A
- Revenue This Year
- ATXG N/A
- MBRX N/A
- Revenue Next Year
- ATXG N/A
- MBRX N/A
- P/E Ratio
- ATXG N/A
- MBRX N/A
- Revenue Growth
- ATXG N/A
- MBRX N/A
- 52 Week Low
- ATXG $0.49
- MBRX $0.40
- 52 Week High
- ATXG $1.18
- MBRX $5.29
- Technical
- Relative Strength Index (RSI)
- ATXG 50.89
- MBRX 50.79
- Support Level
- ATXG $0.69
- MBRX $1.00
- Resistance Level
- ATXG $0.89
- MBRX $1.09
- Average True Range (ATR)
- ATXG 0.10
- MBRX 0.07
- MACD
- ATXG 0.01
- MBRX 0.01
- Stochastic Oscillator
- ATXG 33.94
- MBRX 60.78
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.